Selected research
Market Structure
Global Testosterone Undecanoate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Testosterone Undecanoate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Testosterone Undecanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Testosterone Undecanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Testosterone Undecanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Testosterone Undecanoate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Testosterone Undecanoate include Zhejiang Medicine Co., Zhejiang Xianju Pharmaceutical, Bayer AG, Taro Pharmaceutical, Merck Sharp & Dohme, Endo Pharmaceuticals and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Testosterone Undecanoate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Testosterone Undecanoate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Testosterone Undecanoate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Testosterone Undecanoate market size, projected growth trends, production technologies, key applications, and end-use industries.
Testosterone Undecanoate Segment by Company
Zhejiang Medicine Co.
Zhejiang Xianju Pharmaceutical
Bayer AG
Taro Pharmaceutical
Merck Sharp & Dohme
Endo Pharmaceuticals
Cipla
Testosterone Undecanoate Segment by Type
Injection
Oral
Testosterone Undecanoate Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Testosterone Undecanoate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Testosterone Undecanoate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Testosterone Undecanoate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Testosterone Undecanoate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Testosterone Undecanoate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Testosterone Undecanoate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Testosterone Undecanoate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Testosterone Undecanoate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Oral
Applications
- Primary Hypogonadism
- Hypogonadotropic Hypogonadism
- Late-Onset Hypogonadism
Companies covered
- Zhejiang Medicine Co.
- Zhejiang Xianju Pharmaceutical
- Bayer AG
- Taro Pharmaceutical
- Merck Sharp & Dohme
- Endo Pharmaceuticals
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Testosterone Undecanoate Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Testosterone Undecanoate Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Testosterone Undecanoate Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Testosterone Undecanoate Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Testosterone Undecanoate Market Dynamics
- 2.1 Testosterone Undecanoate Industry Trends
- 2.2 Testosterone Undecanoate Industry Drivers
- 2.3 Testosterone Undecanoate Industry Opportunities and Challenges
- 2.4 Testosterone Undecanoate Industry Restraints
3 Testosterone Undecanoate Market by Manufacturers
- 3.1 Global Testosterone Undecanoate Revenue by Manufacturers (2021-2026)
- 3.2 Global Testosterone Undecanoate Sales by Manufacturers (2021-2026)
- 3.3 Global Testosterone Undecanoate Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Testosterone Undecanoate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Testosterone Undecanoate Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Testosterone Undecanoate Manufacturers, Product Type & Application
- 3.7 Global Testosterone Undecanoate Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Testosterone Undecanoate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Testosterone Undecanoate Players Market Share by Revenue in 2025
- 3.8.3 2025 Testosterone Undecanoate Tier 1, Tier 2, and Tier 3
4 Testosterone Undecanoate Market by Type
- 4.1 Testosterone Undecanoate Type Introduction
- 4.1.1 Injection
- 4.1.2 Oral
- 4.2 Global Testosterone Undecanoate Sales by Type
- 4.2.1 Global Testosterone Undecanoate Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Testosterone Undecanoate Sales by Type (2021-2032)
- 4.2.3 Global Testosterone Undecanoate Sales Market Share by Type (2021-2032)
- 4.3 Global Testosterone Undecanoate Revenue by Type
- 4.3.1 Global Testosterone Undecanoate Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Testosterone Undecanoate Revenue by Type (2021-2032)
- 4.3.3 Global Testosterone Undecanoate Revenue Market Share by Type (2021-2032)
5 Testosterone Undecanoate Market by Application
- 5.1 Testosterone Undecanoate Application Introduction
- 5.1.1 Primary Hypogonadism
- 5.1.2 Hypogonadotropic Hypogonadism
- 5.1.3 Late-Onset Hypogonadism
- 5.2 Global Testosterone Undecanoate Sales by Application
- 5.2.1 Global Testosterone Undecanoate Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Testosterone Undecanoate Sales by Application (2021-2032)
- 5.2.3 Global Testosterone Undecanoate Sales Market Share by Application (2021-2032)
- 5.3 Global Testosterone Undecanoate Revenue by Application
- 5.3.1 Global Testosterone Undecanoate Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Testosterone Undecanoate Revenue by Application (2021-2032)
- 5.3.3 Global Testosterone Undecanoate Revenue Market Share by Application (2021-2032)
6 Global Testosterone Undecanoate Sales by Region
- 6.1 Global Testosterone Undecanoate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Testosterone Undecanoate Sales by Region (2021-2032)
- 6.2.1 Global Testosterone Undecanoate Sales by Region (2021-2026)
- 6.2.2 Global Testosterone Undecanoate Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Testosterone Undecanoate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Testosterone Undecanoate Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Testosterone Undecanoate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Testosterone Undecanoate Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Testosterone Undecanoate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Testosterone Undecanoate Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Testosterone Undecanoate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Testosterone Undecanoate Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Testosterone Undecanoate Revenue by Region
- 7.1 Global Testosterone Undecanoate Revenue by Region
- 7.1.1 Global Testosterone Undecanoate Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Testosterone Undecanoate Revenue by Region (2021-2026)
- 7.1.3 Global Testosterone Undecanoate Revenue by Region (2027-2032)
- 7.1.4 Global Testosterone Undecanoate Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Testosterone Undecanoate Revenue (2021-2032)
- 7.2.2 North America Testosterone Undecanoate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Testosterone Undecanoate Revenue (2021-2032)
- 7.3.2 Europe Testosterone Undecanoate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Testosterone Undecanoate Revenue (2021-2032)
- 7.4.2 Asia-Pacific Testosterone Undecanoate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Testosterone Undecanoate Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Testosterone Undecanoate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhejiang Medicine Co.
- 8.1.1 Zhejiang Medicine Co. Company Information
- 8.1.2 Zhejiang Medicine Co. Business Overview
- 8.1.3 Zhejiang Medicine Co. Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhejiang Medicine Co. Testosterone Undecanoate Product Portfolio
- 8.1.5 Zhejiang Medicine Co. Recent Developments
- 8.2 Zhejiang Xianju Pharmaceutical
- 8.2.1 Zhejiang Xianju Pharmaceutical Company Information
- 8.2.2 Zhejiang Xianju Pharmaceutical Business Overview
- 8.2.3 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhejiang Xianju Pharmaceutical Testosterone Undecanoate Product Portfolio
- 8.2.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 8.3 Bayer AG
- 8.3.1 Bayer AG Company Information
- 8.3.2 Bayer AG Business Overview
- 8.3.3 Bayer AG Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer AG Testosterone Undecanoate Product Portfolio
- 8.3.5 Bayer AG Recent Developments
- 8.4 Taro Pharmaceutical
- 8.4.1 Taro Pharmaceutical Company Information
- 8.4.2 Taro Pharmaceutical Business Overview
- 8.4.3 Taro Pharmaceutical Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Taro Pharmaceutical Testosterone Undecanoate Product Portfolio
- 8.4.5 Taro Pharmaceutical Recent Developments
- 8.5 Merck Sharp & Dohme
- 8.5.1 Merck Sharp & Dohme Company Information
- 8.5.2 Merck Sharp & Dohme Business Overview
- 8.5.3 Merck Sharp & Dohme Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Sharp & Dohme Testosterone Undecanoate Product Portfolio
- 8.5.5 Merck Sharp & Dohme Recent Developments
- 8.6 Endo Pharmaceuticals
- 8.6.1 Endo Pharmaceuticals Company Information
- 8.6.2 Endo Pharmaceuticals Business Overview
- 8.6.3 Endo Pharmaceuticals Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Endo Pharmaceuticals Testosterone Undecanoate Product Portfolio
- 8.6.5 Endo Pharmaceuticals Recent Developments
- 8.7 Cipla
- 8.7.1 Cipla Company Information
- 8.7.2 Cipla Business Overview
- 8.7.3 Cipla Testosterone Undecanoate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Cipla Testosterone Undecanoate Product Portfolio
- 8.7.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Testosterone Undecanoate Value Chain Analysis
- 9.1.1 Testosterone Undecanoate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Testosterone Undecanoate Production Mode & Process
- 9.2 Testosterone Undecanoate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Testosterone Undecanoate Distributors
- 9.2.3 Testosterone Undecanoate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst